Vanguard Global Advisers
TDOC icon

Vanguard Global Advisers’s Teladoc Health TDOC Stock Holding History

Vanguard Global Advisers’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$932K Sell
109,961
-32,761
-23% -$218K ﹤0.01% 1788
2026
Q1 		$778K Buy
+142,722
New +$801K ﹤0.01% 1790

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Vanguard Global Advisers's TDOC Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Teladoc Health (TDOC) stake by 23% in Q2 2026, selling an estimated $218K and leaving 109,961 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #1788.

Vanguard Global Advisers first reported a position in TDOC in Q1 2026 and has held it in 2 quarters since. 343 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Vanguard Global Advisers held 109,961 shares of Teladoc Health worth $932K as of Q2 2026.
  • Vanguard Global Advisers sold 32,761 Teladoc Health shares in Q2 2026, an estimated $218K.
  • Teladoc Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1788 holding.
  • Vanguard Global Advisers first reported a position in Teladoc Health in Q1 2026 and has held it in 2 quarters since.
  • 343 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.